即将举行的活动：2022 年预防宫颈癌会议
2022 年预防宫颈癌会议 (PCC2022) 将于 2022 年 11 月 16 日至 18 日在墨尔本索菲特酒店举行。
这次会议将是一场面对面和虚拟的混合活动，汇集澳大利亚、新西兰和印度洋-太平洋地区的领先专家，讨论为这些地区的妇女和女童实现无宫颈癌的未来。
PCC2022 由澳大利亚宫颈癌预防中心和 NHMRC 资助的宫颈癌控制卓越研究中心主办。
欲了解更多信息并注册参加本次会议，请单击下面的链接。
更新免疫接种参考页：维多利亚州的强制性疫苗接种指南
疫苗授权意味着在某些情况下需要疫苗接种证明或授权的医疗豁免。强制执行通常被认为是优化疫苗接种的后期步骤，因为在执行强制执行之前确保以公平的方式获得疫苗非常重要。疫苗授权可能因司法管辖区而异，并且澳大利亚各地可能存在一些差异。
我们的强制性疫苗说明参考页面最近已更新，包括与维多利亚州个人相关的说明。他们包括：
- 疫苗具体说明
- 政策的具体方向。
要查看完整的更新页面，请点击以下链接：
更新免疫参考页：癫痫和免疫页
癫痫是导致人癫痫发作的大脑疾病。虽然大多数人癫痫的病因通常是未知的，但它可能包括遗传病、脑损伤或感染、出生时缺氧损伤、脑肿瘤或神经退行性疾病。
感染，包括可通过疫苗预防的感染（例如麻疹、流感、COVID-19 等），可引发癫痫患者癫痫发作。虽然通常建议接种疫苗，但我在极少数情况下，疫苗也会引起癫痫发作。这就是为什么在为癫痫患者计划疫苗接种时进行风险/收益评估很重要。
我们的参考页面最近已更新为详细信息：
- 癫痫和疫苗相关癫痫发作
- 遗传性癫痫人群的免疫接种管理，易发生疫苗相关癫痫发作（Dravet 综合征和 GEFS+）
- 免疫建议和管理。
要查看完整页面，请点击以下链接：
更新了免疫参考页：结核病 (BCG)
Tuberculosis (TB) is a bacterial infection that predominantly manifests in the lungs but can spread to other areas of the body including the brain, bones, kidneys and lymph nodes. Whilst Australia has some of the lowest rates of TB in the world, it is estimated that globally one-quarter of the world’s population is infected.
Our reference page has recently been updated to include information on:
- the infection and what to look for
- epidemiology
- vaccination
- tuberculin skin testing.
要查看完整页面，请点击以下链接：
ATAGI 关于 5 至 11 岁儿童接种辉瑞 COVID-19 儿科疫苗加强剂量的建议
ATAGI have recommended COVID-19 booster doses for some groups of 5-11 year olds who have previously completed a primary course of COVID-19 vaccination. Eligible groups include those with severe immunocompromise, a disability with significant or complex health needs, or those with complex/multiple health conditions that increase the risk of severe COVID-19 disease.
Boosters in this age group can be administered 3 or more months after completing a primary course of COVID-19 vaccines. An interval of 3 months between COVID-19 infection and COVID vaccines is recommended.
There is currently not enough evidence to support booster doses for other groups of 5-11 year olds, however recommendations may change as more evidence emerges. All children in this age group are recommended to receive a primary course of COVID-19 vaccination.
To read the recommendations in full please follow the link below.
更新的免疫参考页 – 与疫苗接种相关的肩部损伤 (SIRVA)
Shoulder Injury Related to Vaccine Administration (SIRVA) is a rare but serious complication following suspected inadvertent administration of a vaccine too high in the deltoid or into the shoulder joint. It can cause a local inflammatory response and potential trauma to local structures within the shoulder joint with symptoms lasting for weeks, months or even years.
我们的参考页面最近已更新为详细信息：
- symptoms/features of SIRVA
- impacts and implications
- diagnosis and treatment options
- how to prevent SIRVA
- where to report a case of SIRVA.
要查看完整页面，请点击以下链接：
微血管内皮细胞： Shoulder Injury Related to Vaccine Administration (SIRVA)
立即注册 CVU 2022！
不要忘记报名参加 10 月 28 日星期五举行的年度临床疫苗学更新 (CVU)！
我们的面对面活动将通过主题演讲和互动分组会议提供专业发展，以及与同行交流和交流的机会。
立即注册，不要错过这个机会，聆听顶尖专家介绍免疫领域的最新发展和趋势！
要查看该计划并注册，请点击下面的链接进入我们的活动页面：
MVEC：临床疫苗学更新 (CVU) 2022
更新的免疫参考页：接种 COVID-19 疫苗后的心肌炎和心包炎
MVEC’s myocarditis and pericarditis reference page has been updated following the recent changes to the guidance on myocarditis and pericarditis associated with COVID-19 vaccination.
This update is reflective of ATAGI’s recent advice which has identified that all of the COVID-19 vaccines available within Australia (including non-mRNA COVID-19 vaccines) carry a small increased risk of myocarditis or pericarditis occurring following vaccination.
要查看完整页面，请点击以下链接：
MVEC: Myocarditis and pericarditis following COVID-19 vaccines
Updated immunisation reference page - Pharmacist immunisers
Our pharmacist immuniser reference page has recently been updated to incorporate the expansion of the pharmacist immuniser program allowing accredited pharmacist providers to administer additional vaccines to more people.
Pharmacist immunisers that have completed a recognised ‘Immuniser program of study’, are now authorised to administer the following vaccines in Victoria:
- human papillomavirus (HPV) vaccines to those aged 12 years and older
- pneumococcal vaccines to people aged 50 years and older
- herpes zoster (shingles) vaccine to people aged 50 years and older
- monkeypox vaccines to patients recommended for vaccination aged five years and older.
In addition to this, pharmacist immunisers are now able to administer the diphtheria-tetanus-pertussis (dTpa) vaccine to anyone aged 12 years or older (previously only to those from 15 years of age).
要查看完整页面，请点击以下链接：